- Biocon Biologics has announced multiple market access agreements for its biosimilar Yesintek™ in the United States.
- Yesintek™ is a biosimilar to Stelara® and is now covered for over 1…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]